JFDA announces suspension pf Trifecta GT valve - Mheidat

AMMAN — Jordan Food and Drug Administration (JFDA) has launched procedures to pull out and suspend trading Trifecta GT valve, a specialized artificial heart valve, meant to replace aortic values.اضافة اعلان

In a statement on Thursday, JFDA director general, Nizar Mheidat, said the step, was taken in conjunction with the manufacturer’s decision and United States Food and Drug Administration (FDA)’s warning of potential complications on the patient's health, Jordan News Agency Petra reported.

These measures come as a continuation of JFDA's keenness to take the "maximum" control and preventive measures to ensure that medical supplies in Jordan's market meet the "highest" technical specifications and standards of safety and effectiveness, according to a JFDA statement.


Read more National news
Jordan News